ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

RTW Rtw Biotech Opportunities Ltd

1.58
0.01 (0.64%)
18 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Rtw Biotech Opportunities Ltd LSE:RTW London Ordinary Share GG00BKTRRM22 ORD NPV
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.01 0.64% 1.58 1.57 1.59 1.59 1.56 1.57 214,642 16:35:10
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Trust,ex Ed,religious,charty 4.17M -4.76M -0.0226 -54.87 261.19M

RTW Biotech Opportunities Ltd Total Voting Rights

01/03/2024 7:00am

RNS Regulatory News


RNS Number : 0386F
RTW Biotech Opportunities Ltd
01 March 2024
 

LEI: 549300Q7EXQQH6KF7Z84

1 March 2024

RTW Biotech Opportunities Ltd

(the "Company")

Total Voting Rights

In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1R the Company would like to notify the market of the following:

At the close of business on 29 February  2024, the Company had 394,290,303 Ordinary shares in issue, of which 4,803,791 were held in Treasury. Therefore, the total number of voting rights in the Company was 389,486,512.

The above figure of 389,486,512 may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information contact:

RTW Investments, LP

+44 (0)20 7959 6361

Woody Stileman, Managing Director

Krisha McCune, Director, Investor Relations


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRQKLFLZLLZBBL

1 Year Rtw Biotech Opportunities Chart

1 Year Rtw Biotech Opportunities Chart

1 Month Rtw Biotech Opportunities Chart

1 Month Rtw Biotech Opportunities Chart

Your Recent History

Delayed Upgrade Clock